Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Analysis of Implantation of Stromal Vascular Fraction

NCT03226093 is registered in ClinicalTrials.gov with Bioheart, Inc. as lead sponsor.

NCT NCT03226093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Analysis of Implantation of Stromal Vascular Fraction
Lead sponsor
Bioheart, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2015
Completion date
June 1, 2017
Enrollment
676 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues